BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2651483)

  • 21. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions.
    Gandolfo M; Keszler A; Lanfranchi H; Itoiz ME
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):486-93. PubMed ID: 21420637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation of leukoplakia three times in period of 11-years--case report.
    Amino K; Tsubakimoto Y; Doi T; Sakuda M
    J Osaka Univ Dent Sch; 1995 Dec; 35():13-20. PubMed ID: 9206463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Premalignant lesions of the oral mucosa. Prognosis, treatment and follow-up].
    Merkx MA; ter Hoeven J; de Wilde PC
    Ned Tijdschr Tandheelkd; 2005 Feb; 112(2):51-5. PubMed ID: 15747998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.
    Saito T; Sugiura C; Hirai A; Notani K; Totsuka Y; Shindoh M; Fukuda H
    Int J Oral Maxillofac Surg; 2001 Feb; 30(1):49-53. PubMed ID: 11289621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometric analysis of spinous cell in oral submucous fibrosis. Comparison with normal mucosa, leukoplakia and squamous cell carcinoma.
    Gao S; Liu S; Shen Z; Peng L
    Chin Med J (Engl); 1995 May; 108(5):351-4. PubMed ID: 7555236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
    Chattopadhyay A; Chawda JG; Doshi JJ
    Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma.
    Pindborg JJ; Reibel J; Holmstrup P
    J Oral Pathol; 1985 Oct; 14(9):698-708. PubMed ID: 3932623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
    Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
    Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
    Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
    Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic proliferative verrucous leukoplakia: report of a clinical rarity.
    Singh AP; Chaitra TR; Kulkarni AU; Jathar PN
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22865802
    [No Abstract]   [Full Text] [Related]  

  • 35. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
    Gandolfo S; Castellani R; Pentenero M
    J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive, multifocal oral verrucous leukoplakia: proliferative verrucous leukoplakia or not?
    Ghazali N; Bakri MM; Zain RB
    J Oral Pathol Med; 2003 Aug; 32(7):383-92. PubMed ID: 12846784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukoplakia, dysplasia, and malignant transformation.
    Silverman S; Gorsky M; Kaugars GE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Aug; 82(2):117. PubMed ID: 8863297
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical determinants of malignant transformation in oral epithelial dysplasia.
    Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
    Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
    Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
    J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High risk lesions of the oral mucosa--Diagnosis, therapy and follow-up in two cases].
    Halbritter SA; Spieler P; Bornstein MM
    Schweiz Monatsschr Zahnmed; 2007; 117(7):730-45. PubMed ID: 17708425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.